A new publication concerning icatibant related research appeared on September 3, 2026. The paper, titled "Isolated gastrointestinal hereditary angioedema associated with a pathogenic SERPING1 variant arising de novo: a case report," was published in Frontiers in Medicine.
The publication is listed as a case report. It documents a single case involving a pathogenic SERPING1 variant described as arising de novo, in the context of isolated gastrointestinal hereditary angioedema.
No additional details about study findings, outcomes, or treatment results were provided in the event data. This brief reports only the existence and identification of the publication as indexed, without characterizing its conclusions.
Readers interested in background on icatibant, including its approved regulatory status, can consult the compound overview for further context.